NO20034419L - Antifungalt preparat med forbedret biotilgjengelighet - Google Patents

Antifungalt preparat med forbedret biotilgjengelighet

Info

Publication number
NO20034419L
NO20034419L NO20034419A NO20034419A NO20034419L NO 20034419 L NO20034419 L NO 20034419L NO 20034419 A NO20034419 A NO 20034419A NO 20034419 A NO20034419 A NO 20034419A NO 20034419 L NO20034419 L NO 20034419L
Authority
NO
Norway
Prior art keywords
improved bioavailability
antifungal drug
antifungal
drug
bioavailability
Prior art date
Application number
NO20034419A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034419D0 (no
Inventor
Stefan Sharpe
Joel Sequeira
David Harris
Shashank Mahashabde
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23076102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20034419(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20034419D0 publication Critical patent/NO20034419D0/no
Publication of NO20034419L publication Critical patent/NO20034419L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647—Triazoles; Hydrogenated triazoles
    • A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20034419A 2001-04-03 2003-10-02 Antifungalt preparat med forbedret biotilgjengelighet NO20034419L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28113901P 2001-04-03 2001-04-03
PCT/US2002/010093 WO2002080678A1 (en) 2001-04-03 2002-04-01 Antifungal composition with enhanced bioavailability

Publications (2)

Publication Number Publication Date
NO20034419D0 NO20034419D0 (no) 2003-10-02
NO20034419L true NO20034419L (no) 2003-12-02

Family

ID=23076102

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034419A NO20034419L (no) 2001-04-03 2003-10-02 Antifungalt preparat med forbedret biotilgjengelighet

Country Status (18)

Country Link
US (2) US20030055067A1 (de)
EP (2) EP1372394A1 (de)
JP (2) JP4308902B2 (de)
KR (1) KR100607742B1 (de)
CN (1) CN100415234C (de)
AR (1) AR033096A1 (de)
AU (1) AU2002257104B2 (de)
BR (1) BR0208626A (de)
CA (1) CA2443089C (de)
HU (1) HUP0400856A3 (de)
MX (1) MXPA03009021A (de)
NO (1) NO20034419L (de)
NZ (1) NZ528363A (de)
PE (1) PE20020994A1 (de)
PL (1) PL212985B1 (de)
TW (1) TWI311464B (de)
WO (1) WO2002080678A1 (de)
ZA (1) ZA200307684B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
MXPA04002446A (es) 2001-09-26 2004-07-23 Baxter Int Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
AR049063A1 (es) * 2004-05-28 2006-06-21 Schering Corp Composiciones farmaceuticas inyectables de posaconazol con particulas estabilizadas
US20060160823A1 (en) * 2004-05-28 2006-07-20 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmaceutical compositions of Posaconazole
US20060009469A1 (en) * 2004-05-28 2006-01-12 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmacutical compositions of posaconazole
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
US20070281011A1 (en) 2006-05-30 2007-12-06 Elan Pharma International Ltd. Nanoparticulate posaconazole formulations
MX2008015764A (es) 2006-06-14 2009-01-07 Intervet Int Bv Suspension que comprende carbamato de bencimidazol y polisorbato.
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
FR2910323A1 (fr) * 2006-12-26 2008-06-27 Virbac Sa Sa Composition liquide anhydre destinee a etre incorporee a l'eau de boisson des animaux d'elevage.
DE102008004893A1 (de) * 2008-01-17 2009-07-23 Add Technologies Ltd. Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung
WO2009129301A2 (en) * 2008-04-15 2009-10-22 Schering Corporation Oral pharmaceutical compositions in a molecular solid dispersion
BRPI0910627A2 (pt) * 2008-04-15 2015-09-22 Schering Corp composições de alta densidade contendo posaconazol e formulações compreendendo as mesmas
EP2130540A1 (de) * 2008-06-02 2009-12-09 Sandoz AG Pharmazeutische Zusammensetzungen mit einer kristallinen Form von Posaconazol
EP2141159A1 (de) 2008-07-03 2010-01-06 Sandoz AG Kristalline Form von Posaconazol
WO2011003992A1 (en) 2009-07-09 2011-01-13 Sandoz Ag A crystalline form of posaconazole
BR112012029226A2 (pt) 2010-05-19 2015-10-20 Sandoz Ag processo para a preparação de um composto quiral, composto quiral cristalino, sal de hcl do composto quiral cristalino, composto quiral e uso do composto
MX337804B (es) 2010-05-19 2016-03-18 Sandoz Ag Proceso para la preparacion de hidrazinas quirales.
RU2585760C2 (ru) 2010-05-19 2016-06-10 Сандоз Аг Способ получения хиральных триазолонов
MX2012013331A (es) 2010-05-19 2013-02-01 Sandoz Ag Purificacion de posaconazol y de intermediarios de posaconazol.
CN103635465A (zh) 2011-06-16 2014-03-12 桑多斯股份公司 制备手性化合物的方法
CN104379132A (zh) 2012-06-14 2015-02-25 桑多斯股份公司 包含结晶泊沙康唑的药物组合物
EP3227277B1 (de) 2014-12-05 2020-02-05 Pulmocide Limited Antimykotische verbindung
KR102653821B1 (ko) * 2015-05-21 2024-04-02 풀모사이드 리미티드 항진균성 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-트리아졸-1-일)메틸)-5-(2,4-디플루오로페닐)테트라하이드로푸란-3-일)메톡시)-3-메틸페닐)피페라진-1-일)-n-(2-하이드록시사이클로헥실)벤즈아미드 또는 이의 약학적으로 허용가능한 염.
CN105030668B (zh) * 2015-06-26 2018-03-27 济川药业集团有限公司 泊沙康唑口服混悬剂及其制备方法
CN106333925B (zh) * 2015-07-10 2019-06-18 上海美悦生物科技发展有限公司 一种泊沙康唑液体混悬剂及其制备方法
EP3397629B1 (de) * 2015-12-30 2023-04-19 NQP 1598, Ltd. Metalloenzyminhibitorverbindungen
CN106389390A (zh) * 2016-06-30 2017-02-15 重庆华邦制药有限公司 泊沙康唑涂膜剂及其制备方法
CN107625729A (zh) * 2017-09-29 2018-01-26 重庆华邦制药有限公司 泊沙康唑口服混悬液及其制备方法
CN110507609B (zh) * 2018-05-21 2021-09-17 上海医药工业研究院 泊沙康唑口服混悬剂的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4533254A (en) 1981-04-17 1985-08-06 Biotechnology Development Corporation Apparatus for forming emulsions
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
AU642066B2 (en) 1991-01-25 1993-10-07 Nanosystems L.L.C. X-ray contrast compositions useful in medical imaging
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5552160A (en) 1991-01-25 1996-09-03 Nanosystems L.L.C. Surface modified NSAID nanoparticles
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5661151A (en) * 1993-12-21 1997-08-26 Schering Corporation Tetrahydrofuran antifungals
ES2159623T3 (es) * 1993-12-21 2001-10-16 Schering Corp Antifungicos de tetrahidrofurano.
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5580579A (en) * 1995-02-15 1996-12-03 Nano Systems L.L.C. Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
EP0862917A4 (de) * 1995-11-20 2002-01-09 Banyu Pharma Co Ltd Fungizides mittel
US5834472A (en) * 1996-05-24 1998-11-10 Schering Corporation Antifungal composition with enhanced bioavailability
US5846971A (en) 1996-06-28 1998-12-08 Schering Corporation Oral antifungal composition
US6274634B1 (en) * 1997-05-14 2001-08-14 Senju Pharmaceutical Co., Ltd. Aqueous suspension preparations with excellent redispersibility
EP1079808B1 (de) 1998-05-29 2004-02-11 Skyepharma Canada Inc. Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug

Also Published As

Publication number Publication date
KR100607742B1 (ko) 2006-08-01
KR20030087052A (ko) 2003-11-12
US8263600B2 (en) 2012-09-11
WO2002080678A1 (en) 2002-10-17
PL363965A1 (en) 2004-11-29
US20110244004A1 (en) 2011-10-06
NO20034419D0 (no) 2003-10-02
BR0208626A (pt) 2004-03-09
ZA200307684B (en) 2005-03-30
HUP0400856A3 (en) 2012-09-28
HUP0400856A2 (hu) 2004-08-30
EP2090165A2 (de) 2009-08-19
EP2090165A3 (de) 2012-03-28
NZ528363A (en) 2005-04-29
PE20020994A1 (es) 2002-11-01
CA2443089A1 (en) 2002-10-17
TWI311464B (en) 2009-07-01
JP2004527525A (ja) 2004-09-09
AR033096A1 (es) 2003-12-03
CN1499930A (zh) 2004-05-26
JP2008120836A (ja) 2008-05-29
US20030055067A1 (en) 2003-03-20
AU2002257104B2 (en) 2006-02-09
PL212985B1 (pl) 2012-12-31
JP4308902B2 (ja) 2009-08-05
CA2443089C (en) 2011-11-01
EP1372394A1 (de) 2004-01-02
MXPA03009021A (es) 2004-02-12
CN100415234C (zh) 2008-09-03

Similar Documents

Publication Publication Date Title
NO20034419L (no) Antifungalt preparat med forbedret biotilgjengelighet
NO20033143D0 (no) Farmasoytisk preparat
NO20034026D0 (no) Nytt preparat
NO20030418D0 (no) Nytt farmasöytisk preparat
NO20035208D0 (no) Nytt vaksine preparat
DK3210637T3 (da) Infusionssæt
DE50002776D1 (de) Fungizide wirkstoffkombinationen
DK1383560T4 (da) Infusionssæt
NO20052239D0 (no) Fast preparat
ATE432008T1 (de) Repellentmittel
NO20033203L (no) Terapeutiske heterocykliske forbindelser
NO20034695L (no) Nytt preparat
NO20015149D0 (no) Nytt farmasöytisk preparat
NO20025805L (no) Farmasöytisk preparat
DE50102752D1 (de) Fungizide wirkstoffkombinationen
NO20015148L (no) Nytt farmasöytisk preparat
NO20060375L (no) Famasoytisk preparat
NO20033829D0 (no) Antiviralt preparat
DE50304722D1 (de) Fungizide Wirkstoffkombinationen
DE50007895D1 (de) Fungizide wirkstoffkombinationen
NO20015104L (no) Nytt farmasöytisk preparat
NO20040732L (no) Slagmatte for golf
NO20023392D0 (no) Preparat
NO20015105L (no) Nytt farmasöytisk preparat
DE50002125D1 (de) Fungizide wirkstoffkombinationen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MERCK SHARP AND DOHME CORP., US

Free format text: NEW ADDRESS: 126 EAST LINCOLN AVENUE, US-NJ07065 RAHWAY

FC2A Withdrawal, rejection or dismissal of laid open patent application